First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever

Published:2016-01-05 Issue:7 Volume:62 Page:947.1-949
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Menard Amélie,Colson Philippe,Catherine Dhiver,Isabelle Ravaux,Christelle Tomei,Meddeb Line,Ben Ali Souad,Solas Caroline,Stein Andreas

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/62/7/947/7452643/civ1215.pdf

Reference3 articles.

1. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials

2. Hepatitis C can be cured globally, but at what cost?

3. New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States;Expert Review of Clinical Pharmacology;2019-12-02

2. Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world;International Journal of Clinical Pharmacy;2018-03-20

3. Drug–Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers;Clinical Infectious Diseases;2018-03-07

4. High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands;Clinical Infectious Diseases;2017-11-23

5. Successful treatment of HIV-/HCV-coinfected patients in the era of direct acting antivirals: is advanced liver disease still a limiting factor?;Infectious Diseases;2017-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3